Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Nephroblastoma | Research article

Prevalence of childhood Cancer among children attending referral hospitals of outpatient Department in Ethiopia

Authors: Aklilu Endalamaw, Nega Tezera Assimamaw, Tadesse Awoke Ayele, Achenef Asmamaw Muche, Ejigu Gebeye Zeleke, Amare Wondim, Getaneh Mulualem Belay, Yeneabat Birhanu, Ashenafi Tazebew, Masresha Asmare Techane, Selam Fisha Kassa, Chalachew Adugna Wubneh

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Introduction

Childhood cancer is one of the leading causes of morbidity and mortality in the pediatrics age group. The problem affects both developed and developing countries. A high mortality rate has been observed in low-income counties. Despite its high fatality rate, less attention has been paid to the problem in developing countries, including Ethiopia. For this reason, childhood cancer is not well documented in the study setting. Therefore, we assessed the prevalence of childhood cancer in Ethiopia.

Methods

Institution based cross-sectional study design from January 1, 2019, to March 30, 2019, was conducted in the pediatrics treatment center. A systematic random sampling technique has used to select 1270 children in the pediatric outpatient department. The data were entered using Epi info version 7 and exported to SPSS version 20 for analysis. We checked model fitness for the advanced statistical methods, but it was difficult to proceed with logistic regression model to see the association between dependent and explanatory variables because of the unmet x2 assumption. We presented the results by using tables and figures.

Results

From the total 1270 study participants, 1257 were included in the final analysis provided that a 98.97% response rate. Out of these, 10(0.8%) children were diagnosed with cancer. Regarding its types, two each, Acute Lymphocytic Leukemia, Wilms tumor, Hodgkin lymphoma, and one each non-Hodgkin lymphoma, Parotid cancer, Retinoblastoma, and Breast cancer were reported. The prevalence of childhood cancer was 0.9 and 0.7% among male and female children, respectively.

Conclusions

Eight children diagnosed with cancer per 1000 children who visited the pediatric outpatient department. Even though childhood cancers have little attention from policymakers, the prevalence of childhood cancer remains prevalent. Therefore, researchers and policymakers shall give special emphasis to childhood cancer.
Literature
1.
go back to reference Vineis P. Definition and classification of cancer: monothetic or polythetic? Theor Med. 1993;14(3):249–56.CrossRef Vineis P. Definition and classification of cancer: monothetic or polythetic? Theor Med. 1993;14(3):249–56.CrossRef
2.
go back to reference de Fine LS, Rugbjerg K, Gudmundsdottir T, Bonnesen TG, Asdahl PH, Holmqvist AS, Madanat-Harjuoja L, Tryggvadottir L, Wesenberg F, Hasle H. Long-term inpatient disease burden in the adult life after childhood Cancer in Scandinavia (ALiCCS) study: a cohort study of 21,297 childhood cancer survivors. PLoS Med. 2017;14(5):e1002296.CrossRef de Fine LS, Rugbjerg K, Gudmundsdottir T, Bonnesen TG, Asdahl PH, Holmqvist AS, Madanat-Harjuoja L, Tryggvadottir L, Wesenberg F, Hasle H. Long-term inpatient disease burden in the adult life after childhood Cancer in Scandinavia (ALiCCS) study: a cohort study of 21,297 childhood cancer survivors. PLoS Med. 2017;14(5):e1002296.CrossRef
3.
go back to reference Gupta S, Rivera-Luna R, Ribeiro RC, Howard SC. Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low-and middle-income countries. PLoS Med. 2014;11(6):e1001656.CrossRef Gupta S, Rivera-Luna R, Ribeiro RC, Howard SC. Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low-and middle-income countries. PLoS Med. 2014;11(6):e1001656.CrossRef
4.
go back to reference Parkin M. Childhood cancer in developing countries: environmental factors. Int J Pediatr Hematol Oncol. 1995;2(5):411–7. Parkin M. Childhood cancer in developing countries: environmental factors. Int J Pediatr Hematol Oncol. 1995;2(5):411–7.
5.
go back to reference World Health Organization: International childhood cancer day; 2015. World Health Organization: International childhood cancer day; 2015.
6.
go back to reference Kingham TP, Alatise OI, Vanderpuye V, Casper C, Abantanga FA, Kamara TB, Olopade OI, Habeebu M, Abdulkareem FB, Denny L. Treatment of cancer in sub-Saharan Africa. Lancet Oncol. 2013;14(4):e158–67.CrossRef Kingham TP, Alatise OI, Vanderpuye V, Casper C, Abantanga FA, Kamara TB, Olopade OI, Habeebu M, Abdulkareem FB, Denny L. Treatment of cancer in sub-Saharan Africa. Lancet Oncol. 2013;14(4):e158–67.CrossRef
7.
go back to reference Steliarova-Foucher E, Colombet M, Ries LA, Moreno F, Dolya A, Bray F, Hesseling P, Shin HY, Stiller CA, Bouzbid S. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18(6):719–31.CrossRef Steliarova-Foucher E, Colombet M, Ries LA, Moreno F, Dolya A, Bray F, Hesseling P, Shin HY, Stiller CA, Bouzbid S. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18(6):719–31.CrossRef
8.
go back to reference White Y, Castle VP, Haig A. Pediatric oncology in developing countries: challenges and solutions. J Pediatr. 2013;162(6):1090–1091. e1091.CrossRef White Y, Castle VP, Haig A. Pediatric oncology in developing countries: challenges and solutions. J Pediatr. 2013;162(6):1090–1091. e1091.CrossRef
9.
go back to reference Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103.CrossRef Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103.CrossRef
10.
go back to reference Youlden DR, Baade PD, Green AC, Valery PC, Moore AS, Aitken JF. The incidence of childhood cancer in Australia, 1983–2015, and projections to 2035. Med J Aust. 2020;212(3):113–20.CrossRef Youlden DR, Baade PD, Green AC, Valery PC, Moore AS, Aitken JF. The incidence of childhood cancer in Australia, 1983–2015, and projections to 2035. Med J Aust. 2020;212(3):113–20.CrossRef
11.
go back to reference Ba-Saddik IA. Childhood cancer in Aden, Yemen. Cancer Epidemiol. 2013;37(6):803–6.CrossRef Ba-Saddik IA. Childhood cancer in Aden, Yemen. Cancer Epidemiol. 2013;37(6):803–6.CrossRef
12.
go back to reference Federal Ministry of Health Ethiopia. National Cancer Control Plan 2016–2020 of Ethiopia. Prev Control Dir. 2015;2015(10):83. Federal Ministry of Health Ethiopia. National Cancer Control Plan 2016–2020 of Ethiopia. Prev Control Dir. 2015;2015(10):83.
13.
go back to reference Yifru S, Muluye D. Childhood cancer in Gondar university hospital, Northwest Ethiopia. BMC Res Notes. 2015;8(1):474.CrossRef Yifru S, Muluye D. Childhood cancer in Gondar university hospital, Northwest Ethiopia. BMC Res Notes. 2015;8(1):474.CrossRef
14.
go back to reference Travasso C. Indian health ministry told to develop a framework for cancer screening. London: British Medical Journal Publishing Group; 2016. Travasso C. Indian health ministry told to develop a framework for cancer screening. London: British Medical Journal Publishing Group; 2016.
15.
go back to reference Elnuweiry HA, Abed Y. Risk factors for paediatric cancer in the Gaza strip: a case-control study. Lancet. 2018;391:S13.CrossRef Elnuweiry HA, Abed Y. Risk factors for paediatric cancer in the Gaza strip: a case-control study. Lancet. 2018;391:S13.CrossRef
16.
go back to reference Hawkins M, Wilson L, Stovall M, Marsden H, Potok M, Kingston J, Chessells J. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. Br Med J. 1992;304(6832):951–8.CrossRef Hawkins M, Wilson L, Stovall M, Marsden H, Potok M, Kingston J, Chessells J. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. Br Med J. 1992;304(6832):951–8.CrossRef
17.
go back to reference Cardis E, Hatch M. The Chernobyl accident—an epidemiological perspective. Clin Oncol. 2011;23(4):251–60.CrossRef Cardis E, Hatch M. The Chernobyl accident—an epidemiological perspective. Clin Oncol. 2011;23(4):251–60.CrossRef
18.
go back to reference Linet MS, Pyo Kim K, Rajaraman P. Children’s exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations. Pediatr Radiol. 2009;39(1):4–26.CrossRef Linet MS, Pyo Kim K, Rajaraman P. Children’s exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations. Pediatr Radiol. 2009;39(1):4–26.CrossRef
19.
go back to reference Hsu W-L, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, Kimura A, Kamada N, Dohy H, Tomonaga M. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950–2001. Radiat Res. 2013;179(3):361–82.CrossRef Hsu W-L, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, Kimura A, Kamada N, Dohy H, Tomonaga M. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950–2001. Radiat Res. 2013;179(3):361–82.CrossRef
20.
go back to reference Spector LG, Pankratz N, Marcotte EL. Genetic and nongenetic risk factors for childhood cancer. Pediatr Clin. 2015;62(1):11–25. Spector LG, Pankratz N, Marcotte EL. Genetic and nongenetic risk factors for childhood cancer. Pediatr Clin. 2015;62(1):11–25.
21.
go back to reference Stefan DC. Patterns of distribution of childhood cancer in Africa. J Trop Pediatr. 2015;61(3):165–73.CrossRef Stefan DC. Patterns of distribution of childhood cancer in Africa. J Trop Pediatr. 2015;61(3):165–73.CrossRef
22.
go back to reference Arora R, Eden T, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46(4):264.CrossRef Arora R, Eden T, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46(4):264.CrossRef
23.
go back to reference Gelibo T, Getachew T, Bekele A, Defar A, Amenu K, Taddesse M, Teklie H, Assefa Y, Kebede A. Availability and readiness of services for cancer care at health facilities in Ethiopia: implication for action. Ethiop J Health Dev. 2017;31(1):391–6. Gelibo T, Getachew T, Bekele A, Defar A, Amenu K, Taddesse M, Teklie H, Assefa Y, Kebede A. Availability and readiness of services for cancer care at health facilities in Ethiopia: implication for action. Ethiop J Health Dev. 2017;31(1):391–6.
24.
go back to reference Force LM, Abdollahpour I, Advani SM, Agius D, Ahmadian E, Alahdab F, Alam T, Alebel A, Alipour V, Allen CA. The global burden of childhood and adolescent cancer in 2017: an analysis of the global burden of disease study 2017. Lancet Oncol. 2019;20(9):1211–25.CrossRef Force LM, Abdollahpour I, Advani SM, Agius D, Ahmadian E, Alahdab F, Alam T, Alebel A, Alipour V, Allen CA. The global burden of childhood and adolescent cancer in 2017: an analysis of the global burden of disease study 2017. Lancet Oncol. 2019;20(9):1211–25.CrossRef
25.
go back to reference Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali S, Castillo L, Israels T, Jeha S, Harif M, Sullivan MJ, et al. Toward the cure of all children with Cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol. 2015;33(27):3065–73.CrossRef Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali S, Castillo L, Israels T, Jeha S, Harif M, Sullivan MJ, et al. Toward the cure of all children with Cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol. 2015;33(27):3065–73.CrossRef
26.
27.
go back to reference Baade P, Youlden D, Valery P, Hassall T, Ward L, Green A, Aitken J. Trends in incidence of childhood cancer in Australia, 1983–2006. Br J Cancer. 2010;102(3):620–6.CrossRef Baade P, Youlden D, Valery P, Hassall T, Ward L, Green A, Aitken J. Trends in incidence of childhood cancer in Australia, 1983–2006. Br J Cancer. 2010;102(3):620–6.CrossRef
28.
go back to reference Stefan DC, Baadjes B, Kruger M. Incidence of childhood cancer in Namibia: the need for registries in Africa. Pan Afr Med J. 2014;17. Stefan DC, Baadjes B, Kruger M. Incidence of childhood cancer in Namibia: the need for registries in Africa. Pan Afr Med J. 2014;17.
29.
go back to reference Elhassan MM, Mohamedani AA, Yousif NO, Elhaj NM, Qaddoumi I, Abuidres DO. Epidemiological review of childhood cancers in Central Sudan. SA J Oncol. 2018;2(1):1–7. Elhassan MM, Mohamedani AA, Yousif NO, Elhaj NM, Qaddoumi I, Abuidres DO. Epidemiological review of childhood cancers in Central Sudan. SA J Oncol. 2018;2(1):1–7.
30.
go back to reference Borah R, Kouya FT. Epidemiology of pediatric cancer in the Northwest Region of Cameroon. medRxiv. 2020. Borah R, Kouya FT. Epidemiology of pediatric cancer in the Northwest Region of Cameroon. medRxiv. 2020.
31.
go back to reference Kruger M, Hendricks M, Davidson A, Stefan CD, van Eyssen AL, Uys R, van Zyl A, Hesseling P. Childhood cancer in Africa. Pediatr Blood Cancer. 2014;61(4):587–92.CrossRef Kruger M, Hendricks M, Davidson A, Stefan CD, van Eyssen AL, Uys R, van Zyl A, Hesseling P. Childhood cancer in Africa. Pediatr Blood Cancer. 2014;61(4):587–92.CrossRef
32.
go back to reference Tefera B, Assefa M, Abebe B, Rauch D. Patterns of Cancer in University of Gondar Hospital: north-West Ethiopia. J Oncol Med Pract. 2016;1(106):2. Tefera B, Assefa M, Abebe B, Rauch D. Patterns of Cancer in University of Gondar Hospital: north-West Ethiopia. J Oncol Med Pract. 2016;1(106):2.
33.
go back to reference Israëls T. Aspects of the management of children with cancer in Malawi, vol. 51; 2008. Israëls T. Aspects of the management of children with cancer in Malawi, vol. 51; 2008.
Metadata
Title
Prevalence of childhood Cancer among children attending referral hospitals of outpatient Department in Ethiopia
Authors
Aklilu Endalamaw
Nega Tezera Assimamaw
Tadesse Awoke Ayele
Achenef Asmamaw Muche
Ejigu Gebeye Zeleke
Amare Wondim
Getaneh Mulualem Belay
Yeneabat Birhanu
Ashenafi Tazebew
Masresha Asmare Techane
Selam Fisha Kassa
Chalachew Adugna Wubneh
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08014-0

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine